Study title: Comparison of anti-IgE and anti-HLA immune responses after HAVRIX versus VAQTA inactivated Hepatitis A vaccine - "Comparison of immunogenicity of two hepatitis A vaccines - VAQTA® and HAVRIX® - in young adults." Ashur, Y., et al., Vaccine 17: 2290-2296, 1999 )
Type of medicine: Non-centrally authorised vaccines | |||||
Therapeutic area: Virus Diseases | |||||
Brands: Please see report, Please see report, Please see report | |||||
MAH holders: Please see report | |||||
Assessment: | |||||
Active substance: Inactivated hepatitis A virus | |||||
ATC code: J07BC02 | |||||
Document link: | |||||
Document date: | |||||
Study number: P995 | |||||
EudraCT number: | |||||
Scope of study: CLINICAL | |||||
Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
- | - | - | - | - |